Sehatpour P, Javitt DC, De Baun HM, Carlson M, et al. Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058. Neuropsychopharmacology 2022;47:711-718.
PMID: 34667294